Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221.
Saved in:
| Title: | Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221. |
|---|---|
| Authors: | Chen CS; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA., Zirpoli G; Slone Epidemiology Center, Boston University, Boston, MA, USA., Budd GT; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA., Barlow WE; Cancer Research and Biostatistics, Seattle, WA, USA., Pusztai L; Yale School of Medicine, New Haven, CT, USA., Hortobagyi GN; Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA., Godwin AK; Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Thompson A; Baylor College of Medicine, Houston, TX, USA., Henry NL; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Stringer KA; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA.; NMR Metabolomics Laboratory, University of Michigan College of Pharmacy, Ann Arbor, MI, USA., Hertz DL; Department of Clinical Pharmacy, University of Michigan College of Pharmacy, 428 Church St. 1100 North University Building Room 2560C, Ann Arbor, MI, 48109-1065, USA. dlhertz@med.umich.edu.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. dlhertz@med.umich.edu. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Aug; Vol. 94 (2), pp. 311-321. Date of Electronic Publication: 2024 May 30. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-024-04680-6 |
